MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
a study on Breast Cancer
Breast Cancer, stage I, stage II, stage III, Breast Neoplasms, MammaPrint, BluePrint, and Full-Genome Testing, MammaPrint and BluePrint testing
Lead Scientists at UCSF
- Rita Mukhtar, MD
Dr. Rita Mukhtar specializes in breast surgery and general surgery for urgent conditions. For her patients with breast cancer, she offers expertise in total skin-sparing mastectomies, breast conservation, wire localization surgery (used to show the location of tissue requiring biopsy) and sentinel lymph node biopsy (used to see if cancer has spread).
- Laura Esserman, MD
Dr. Laura Esserman, M.D., M.B.A is a surgeon and breast cancer oncology specialist practicing at the UCSF Breast Care Center where she has also held the position of Director since 1996. She co-leads the Breast Oncology Program, the largest of the UCSF Helen Diller Comprehensive Cancer Center's multidisciplinary programs.
- accepting new patients
- Start Date
- Completion Date
- Study Type
- Observational [Patient Registry]
- Expecting 25000 study participants
- Last Updated